Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 A resolution

Science
A R SieleckiM N James

Abstract

The x-ray crystal structure of recombinant human renin has been determined. Molecular dynamics techniques that included crystallographic data as a restraint were used to improve an initial model based on porcine pepsinogen. The present agreement factor for data from 8.0 to 2.5 angstroms (A) is 0.236. Some of the surface loops are poorly determined, and these disordered regions border a 30 A wide solvent channel. Comparison of renin with other aspartyl proteinases shows that, although the structural cores and active sites are highly conserved, surface residues, some of which are critical for specificity, vary greatly (up to 10A). Knowledge of the actual structure, as opposed to the use of models based on related enzymes, should facilitate the design of renin inhibitors.

Citations

Jul 1, 1992·Medicinal Research Reviews·M D Walkinshaw
Nov 1, 1993·Medicinal Research Reviews·S S Abdel-Meguid
Dec 1, 1996·Protein Science : a Publication of the Protein Society·F Grueninger-LeitchC Chène
May 6, 1998·Protein Science : a Publication of the Protein Society·A R Khan, M N James
Jan 1, 1990·Proteins·I T Weber
Feb 1, 1992·Proteins·A SaliT L Blundell
Dec 1, 1996·Journal of Computer-aided Molecular Design·S Ołdziej, J Ciarkowski
Dec 1, 1990·Journal of Protein Chemistry·T F HolzmanG A Krafft
Oct 1, 1990·Journal of Protein Chemistry·K R AcharyaH A Scheraga
Dec 1, 1991·Experientia·R J Breckenridge
Dec 24, 2011·Naunyn-Schmiedeberg's Archives of Pharmacology·Thomas GossasU Helena Danielson
Jul 16, 2008·Current Hypertension Reports·Brian K Dockery, John D Bisognano
Jun 1, 1992·The International Journal of Biochemistry·T C WoonD P Fairlie
Jan 1, 1994·Pharmacology & Therapeutics·J M WoodJ Maibaum
Apr 1, 1993·Immunology Letters·J L PellequerM H Van Regenmortel
Sep 1, 1990·Journal of Molecular Graphics·Y ShiratoriH Umeyama
Jul 2, 2005·The Journal of Allergy and Clinical Immunology·Sabina WünschmannAnna Pomés
Dec 2, 1999·FEBS Letters·V Schauer-VukasinovicT Giller
Jul 1, 1995·Baillière's Clinical Endocrinology and Metabolism·J Peters
Mar 15, 2008·Nature Reviews. Drug Discovery·Chris JensenHans Rudolf Brunner
Jul 17, 2012·Physical Chemistry Chemical Physics : PCCP·Natércia F BrásPedro A Fernandes
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·E T BaldwinJ W Erickson
Sep 17, 1996·Proceedings of the National Academy of Sciences of the United States of America·A M SilvaJ W Erickson
Dec 22, 1999·Journal of Cardiovascular Pharmacology·O ValdenaireW Fischli
Apr 9, 1998·Bioscience, Biotechnology, and Biochemistry·U M NasirY Nakamura
Jul 31, 1999·Bioscience, Biotechnology, and Biochemistry·U M NasirY Nakamura
Apr 19, 2011·World Journal of Cardiology·Gaurav Alreja, Jacob Joseph
Sep 20, 2005·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Martin Fusek, Václav Vetvicka
Jun 23, 2011·Heart Failure Reviews·Nicolas F SchrotenRudolf A de Boer
Apr 10, 2008·Journal of Hypertension·Maarten Adh SchalekampAh Jan Danser
Jun 5, 1995·FEBS Letters·S D FowlerP J Tatnell
Sep 4, 2008·Expert Opinion on Emerging Drugs·Helmy SiragyDavid C Lieb
Jan 1, 1991·Critical Reviews in Biochemistry and Molecular Biology·C Hutchins, J Greer
Jul 12, 1993·FEBS Letters·J HillJ Kay

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.